In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT için istatistikler

Toplam ziyaret

views
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT 2

Aylık toplam ziyaret

views
Ekim 2024 0
Kasım 2024 0
Aralık 2024 2
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0